Literature DB >> 16019575

The neuromuscular junction: anatomical features and adaptations to various forms of increased, or decreased neuromuscular activity.

Meredith H Wilson1, Michael R Deschenes.   

Abstract

The neuromuscular junction (NMJ) allows communication between motor neurons and muscle fibers. During development, marked morphological changes occur as the functional NMJ is formed. During the postnatal period of rapid growth and muscle enlargement, endplate size concurrently increases. Even beyond this period of pronounced plasticity, the NMJ undergoes subtle morphological remodeling--expansion and retraction--although its overall dimensions remain stable. This natural, continual NMJ remodeling is amplified with alterations in neuromuscular activity. Increased activity, presented by exercise training, typically results in expansion of NMJ size. Disuse, brought about by neurotoxins, denervation, or spaceflight, also elicits substantial reconfiguring of the endplate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019575     DOI: 10.1080/00207450590882172

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  26 in total

Review 1.  Role of exercise in maintaining the integrity of the neuromuscular junction.

Authors:  Hiroshi Nishimune; John A Stanford; Yasuo Mori
Journal:  Muscle Nerve       Date:  2013-12-17       Impact factor: 3.217

Review 2.  Presynaptic active zones of mammalian neuromuscular junctions: Nanoarchitecture and selective impairments in aging.

Authors:  Yomna Badawi; Hiroshi Nishimune
Journal:  Neurosci Res       Date:  2017-12-06       Impact factor: 3.304

3.  On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease.

Authors:  Tatsuya Osaki; Sebastien G M Uzel; Roger D Kamm
Journal:  Nat Protoc       Date:  2020-01-13       Impact factor: 13.491

4.  What is Normal? Neuromuscular junction reinnervation after nerve injury.

Authors:  Bianca Vannucci; Katherine B Santosa; Alexandra M Keane; Albina Jablonka-Shariff; Chuieng-Yi Lu; Ying Yan; Matthew MacEwan; Alison K Snyder-Warwick
Journal:  Muscle Nerve       Date:  2019-08-23       Impact factor: 3.217

5.  PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy.

Authors:  Christoph Handschin; Yvonne M Kobayashi; Sherry Chin; Patrick Seale; Kevin P Campbell; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2007-04-01       Impact factor: 11.361

6.  Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation.

Authors:  Lisa M Larkin; Carol S Davis; Catrina Sims-Robinson; Tatiana Y Kostrominova; Holly Van Remmen; Arlan Richardson; Eva L Feldman; Susan V Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-07       Impact factor: 3.619

Review 7.  Compression Garments and Recovery from Exercise: A Meta-Analysis.

Authors:  Freddy Brown; Conor Gissane; Glyn Howatson; Ken van Someren; Charles Pedlar; Jessica Hill
Journal:  Sports Med       Date:  2017-11       Impact factor: 11.136

8.  Macrophage-Derived Vascular Endothelial Growth Factor-A Is Integral to Neuromuscular Junction Reinnervation after Nerve Injury.

Authors:  Chuieng-Yi Lu; Katherine B Santosa; Albina Jablonka-Shariff; Bianca Vannucci; Anja Fuchs; Isaiah Turnbull; Deng Pan; Matthew D Wood; Alison K Snyder-Warwick
Journal:  J Neurosci       Date:  2020-11-06       Impact factor: 6.167

9.  Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.

Authors:  Stephen J P Pratt; Sameer B Shah; Christopher W Ward; Mario P Inacio; Joseph P Stains; Richard M Lovering
Journal:  J Physiol       Date:  2012-10-29       Impact factor: 5.182

10.  Glia and muscle sculpt neuromuscular arbors by engulfing destabilized synaptic boutons and shed presynaptic debris.

Authors:  Yuly Fuentes-Medel; Mary A Logan; James Ashley; Bulent Ataman; Vivian Budnik; Marc R Freeman
Journal:  PLoS Biol       Date:  2009-08-25       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.